Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4165-4169

  Hagiwara, Koichi ^a   McMenamin, Mary G ^a   Miura, Ko ^a   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P53; PROTEIN P63; PROTEIN P73; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; DNA POLYMORPHISM; GENE MUTATION; HUMAN; HUMAN CELL; INTRON; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA-BINDING PROTEINS; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; INTRONS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; PHOSPHOPROTEINS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0033199888     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kaelin, W. G. J. The emerging p53 family. J. Natl. Cancer Inst., 91: 594-598, 1999.
2. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J-C., Valent, A., Minty, A., Chalon, P., Lelias, J-M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90: 809-819, 1997.
3. Senoo, M., Seki, N., Ohira, M., Sugano, S., Watanabe, M., Tachibana, M., Tanaka, T., Shinkai, Y., and Kato, H. A second p53-related protein, p73L, with high homology to p73. Biochem. Biophys. Res. Commun., 248: 603-607, 1998.
4. Osada, M., Ohba, M., Kawahara, C., Ishioka, C., Kanamaru, R., Katoh, I., Ikawa, Y., Nimura, Y., Nakagawara, A., Obinata, M., and Ikawa, S. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med., 4: 839-843, 1998.
5. Trink, B., Okami, K., Wu, L., Sriuranpong, J., Jen, J., and Sidransky, D. A new human p53 homologue. Nat. Med., 4: 747-748, 1998.
6. Augustin, M., Bamberger, C., Paul, D., and Schmale, H. Cloning and chromosomal mapping of the human p53-related KET gene to chromosome 3q27 and its murine homolog Ket to mouse chromosome 16. Mamm. Genome, 9: 899-902, 1998.
7. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dötsch, V., Andrews, N. C., Caput, D., and McKeon, F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell, 2: 305-316, 1998.
8. Mills, A. A., Zheng, B., Wang, X-J., Vogel, H., Roop, D. R., and Bradley, A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature (Lond.), 398: 708-713, 1999.
9. Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., and McKeon, F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature (Lond.), 398: 714-718, 1999.
10. Armstrong, J. F., Kaufman, M. H., Harrison, D. J., and Clarke, A. R. High-frequency developmental abnormalities in p53-deficient mice. Curr. Biol., 5: 931-936, 1995.
11. Ohyama, K., Chung, C. H., Chen, E., Gibson, C. W., Misof, K., Fratzl, P., and Shapiro, I. M. p53 influences mice skeletal development. J. Craniofacial Genet. Dev. Biol., 17: 161-171, 1997.
12. Choi, J., and Donehower, L. A. p53 in embryonic development: maintaining a fine balance. Cell. Mol. Life Sci., 55: 38-47, 1999.
13. Tani, M., Shimizu, K., Kawahara, C., Kohno, T., Ishimoto, O., Ikawa, S., and Yokota, J. Mutation and expression of the p51 gene in human lung cancer. Neoplasia, 1: 71-79, 1999.
14. Hagiwara, K., and Harris, C. C. "Long distance sequencer" method: a novel strategy for large DNA sequencing projects. Nucleic Acids Res., 24: 2460-2461, 1996.
15. Takenoshita, S., Hagiwara, K., Nagashima, M., Gemma, A., Bennett, W. P., and Harris, C. C. The genomic structure of the gene encoding the human transforming growth factor β type II receptor (TGF-β RII). Genomics, 36: 341-344, 1996.
16. Takenoshita, S., Mogi, A., Nagashima, M., Ke, Y., Nagamachi, Y., Miyazono, K., and Hagiwara, K. Characterization of the human Smad2 gene: its promoter sequence and activity, exon-intron structure, 3′ end sequence and expression of the Smad2 mRNA. Genomics, 48: 1-11, 1998.
17. Breathnach, R., Benoist, C., O'Hara, K., Gannon, F., and Chambon, P. Ovalbumin gene: evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries. Proc. Natl. Acad. Sci. USA, 75: 4853-4857, 1978.
18. Mai, M., Huang, H., Reed, C., Qian, C., Smith, J. S., Alderete, B., Jenkins, R., and Smith, D. I. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions. Genomics, 51: 359-363, 1998.
19. Yoshikawa, H., Nagashima, M., Khan, M. A., McMenamin, M. G., Hagiwara, K., and Harris, C. C. Mutational analysis of p73 and p53 in human cancer cell lines. Oncogene, 18: 3415-3421, 1999.
20. Chene, P. In vitro analysis of the dominant negative effect of p53. J. Mol. Biol., 14: 205-209, 1998.
21. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
22. Corn, P. G., Kuerbitz, S. J., van Noesel, M. M., Esteller, M., Compitello, N., Baylin, S. B., and Herman, J. G. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′CpG island methylation. Cancer Res., 59: 3352-3356, 1999.